Palivizumab, CAS [[188039-54-5]] Preis auf Anfrage

Catalog Number: MCE-HY-P9944
Article Name: Palivizumab, CAS [[188039-54-5]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-P9944
Supplier Catalog Number: HY-P9944
Alternative Catalog Number: MCE-HY-P9944-5MG,MCE-HY-P9944-100MG,MCE-HY-P9944-50MG,MCE-HY-P9944-25MG,MCE-HY-P9944-10MG,MCE-HY-P9944-1MG
Manufacturer: MedchemExpress
Category: Antikörper
Alternative Names: MEDI 493
Palivizumab (MEDI 493) is a humanized monoclonal antibody against respiratory syncytial virus (RSV). Palivizumab can bind to RSV F protein with a Kd value of 1.4 nM. Palivizumab can prevent respiratory syncytial virus infection in cotton mice[1].
Molecular Weight: (145.5 kDa)
Purity: 99.63
CAS Number: [188039-54-5]
Target: RSV
Application Notes: MCE Product type: Inhibitory Antibodies